Galectin Therapeutics News

Galectin Therapeutics Presents 3 Abstracts At The American Association For The Study Of Liver Diseases 2024 Liver Meeting

BenzingaNov 18 21:01

Earnings Week Ahead: NVDA, WMT, SNOW, TGT, BIDU, NIO, ZIM, and More

Seeking AlphaNov 18 13:09

H.C. Wainwright Maintains Galectin Therapeutics(GALT.US) With Buy Rating, Maintains Target Price $11

Futu NewsNov 15 20:33 · Ratings

Optimistic Buy Rating for Galectin Therapeutics: Strategic Trial Design and Financial Stability Boost Prospects

TipRanksNov 15 19:35 · Ratings

Galectin Therapeutics Reports Increased Q3 Losses

TipRanksNov 15 12:24

Galectin Therapeutics Believes It Has Sufficient Cash to Fund Planned Ops and Research Through May >GALT

Dow JonesNov 14 21:10

Galectin Therapeutics: NAVIGATE Trial on Track for Top-Line Results in Dec >GALT

Dow JonesNov 14 21:10

Galectin Therapeutics | 8-K: Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2024 and Provides Business Update

SECNov 14 21:01

Galectin Therapeutics Q3 2024 GAAP EPS $(0.18) Misses $(0.12) Estimate

BenzingaNov 14 21:00

Press Release: Galectin Therapeutics Reports Financial Results for the Quarter Ended September 30, 2024 and Provides Business Update

Dow JonesNov 14 21:00

Galectin Therapeutics | 10-Q: Q3 2024 Earnings Report

SECNov 14 20:56 · Announcements

Daily Options Tracker | Tesla options volume surges! Bullish call up to $400; Cryptocurrency stocks skyrocket! MSTR one call option earns 54 times profit.

The volume of MARA options exceeded 0.9 million contracts, increasing more than twofold compared to the previous period, with a call ratio as high as 80%. The implied volatility rose by 38% to a relatively high level for the year, and both Coinbase and microstrategy have call ratios above 70%.

Futu NewsNov 12 17:17

Express News | Galectin Therapeutics Announces Acceptance of Three Abstracts for the American Association for the Study of Liver Diseases (Aasld) 2024 Liver Meeting

BreakingsOct 15 20:00

Galectin Therapeutics Announces Acceptance of Three Abstracts for the American Association for the Study of Liver Diseases (AASLD) 2024 Liver Meeting

GlobeNewswireOct 15 20:00

Galectin Therapeutics Unveils Future Plans and Drug Potential

TipRanksSep 9 20:28

Galectin Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference

Yahoo FinanceSep 3 20:30

Buy Rating Affirmed for Galectin Therapeutics Ahead of Phase 2b Interim Analysis and With Strong Cash Position

TipRanksAug 20 16:45 · Ratings

HC Wainwright & Co. Reiterates Buy on Galectin Therapeutics, Maintains $11 Price Target

BenzingaAug 16 18:41 · Ratings

Galectin Therapeutics Analyst Ratings

BenzingaAug 16 18:39 · Ratings

Galectin Therapeutics 2Q Net $12.4M >GALT

Dow JonesAug 13 20:04